首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

歐洲生物加工市場預測至 2031 年 - 區域分析 - 按產品、營運規模、製程、應用和最終用戶

市場調查報告書

商品編碼

1597074

歐洲生物加工市場預測至 2031 年 - 區域分析 - 按產品、營運規模、製程、應用和最終用戶

Europe Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product, Scale of Operation, Process, Application, and End User

出版日期: 2024年10月03日 | 出版商:

The Insight Partners | 英文 167 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023年歐洲生物加工市場價值為62.165億美元，預計到2031年將達到168.0347億美元；預計2023年至2031年複合年成長率為13.2%。

不斷成長的生物製藥產業推動歐洲生物加工市場

在生物製藥產業，始終需要改進的生物製程來解決新的監管要求、品質控制要求以及生物製品、細胞培養滴定和生物學名藥生產中的生產問題。近年來，生物製藥產業以前所未有的速度成長。生物製藥公司正在研發上花費巨額資金，以推出具有增強的醫療和商業效力的新分子，用於各種治療應用。由於生物製程在生物製劑和生物相似藥的研究、開發和製造中的廣泛應用，其接受度逐漸提高。大型製藥公司和合約研究組織正在開發新的藥物和治療形式來治療多種適應症。此外，對治療慢性病的生物製劑和生物相似藥的強勁需求反過來又推動了生物製藥行業的成長。生物製藥產業是對經濟最重要的貢獻者之一。生物製品批准增加、生物學名藥管道不斷增加、研究活動投資增加以及對開發負擔得起的生物製品的日益關注等因素正在促進生物製藥行業的成長。

除此之外，基因和細胞療法的批准不斷增加有利於生物加工市場的成長。核准的基因療法有 Glybera（用於治療脂蛋白脂肪酶缺乏症）和 Strimvelis（用於治療 ADA 嚴重複合型免疫缺陷症）。因此，上述因素增加了對各種治療藥物大規模生產的需求，從而促進了生物加工市場的成長。

歐洲生物加工市場概況

生物相似藥引入了競爭並提高了生物製劑的可負擔性，最終提供節省成本和增值服務來支持患者護理和醫療保健行業。醫療保健專業人員可以以更低的成本使用高品質的生物製劑治療更多患者。由於節省成本的巨大潛力，德國衛生部推出了一項新法律來增加生物相似藥的採用。此外，國際參與者之間越來越多的合作夥伴關係也促進了該國市場的成長。例如，2020 年 11 月，Hitachi Chemical Advanced Therapeutics Solutions, LLC 和 apceth Biopharma GmbH 擴大了與 Bluebird Bio 的關係，簽訂長期開發和製造服務協議，用於多種療法的臨床和商業供應，並擴大商業藥物ZYNTEGLO在歐洲的產品生產能力，這是一種用於輸血依賴性BETA-地中海貧血（TDT）的一次性基因療法。此外，由於眾多生技公司、高科技研究實驗室以及大量的研發資金的存在，德國的生物技術產業呈現出巨大的成長。生物製藥和生物製劑研發的成長主要是由醫療保健產業公司採用各種有機策略所推動的。例如，2021 年 6 月，Rentschler Biopharma 擴建了 2,000 公升生物反應器的產能，以滿足對複雜抗體不斷成長的需求，複雜抗體是一類具有持續高潛力的生物製藥藥物。同樣，2023 年8 月，生物製藥行業領先供應商之一賽多利斯與全球技術和軟體領導者艾默生合作，將賽多利斯的Biostat STR 第3 代系列生物反應器與艾默生的DeltaVTM 分散式控制系統(DCS) 整合。因此，由於生物製藥公司研發支出的增加，該國的生物製藥產業正在成長。因此，該國生物製藥和生物技術公司的合作研究努力影響市場。

歐洲生物加工市場收入及 2031 年預測（百萬美元）

歐洲生物加工市場細分

歐洲生物加工市場按產品、經營規模、製程、應用、最終用戶和國家分類。

根據產品，歐洲生物加工市場分為儀器和消耗品及配件。到2023年，儀器儀表領域將佔據更大的市場佔有率。此外，生物反應器細分分為中試規模、全規模和實驗室規模。此外，分段層析系統又分為液相層析、氣相層析等。此外，消耗品和配件細分為試劑、細胞培養基、層析樹脂等。

從營運規模來看，歐洲生物加工市場分為商業營運和臨床營運。 2023年，商業營運領域佔據更大的市場佔有率。

依製程分類，歐洲生物加工市場分為下游生物製程和上游生物製程。到2023年，下游生物製程領域將佔據更大的市場佔有率。

根據應用，歐洲生物加工市場分為單株抗體、疫苗、重組蛋白、細胞和基因治療等。 2023 年，單株抗體細分市場佔最大市場。

就最終用戶而言，歐洲生物加工市場分為生物製藥公司、合約製造組織等。 2023 年，生物製藥公司細分市場佔最大市場。

按國家/地區分類，歐洲生物加工市場分為德國、法國、義大利、英國、西班牙和歐洲其他地區。 2023 年，德國在歐洲生物加工市場佔有率中佔據主導地位。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc 和 Cytiva US LLC。是歐洲生物加工市場上的一些領先公司。

In the biopharmaceutical industry, improved bioprocesses are always in demand to address new regulatory requirements, quality control requirements, and production issues in biological products, cell culture titration, and biosimilar production. In recent years, the biopharmaceutical industry has been growing at an unprecedented pace. Biopharmaceutical companies are spending huge sums in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. The acceptance of bioprocessing is gradually increasing due to its wide application in research, development, and manufacturing of biologics and biosimilars. Big pharmaceutical companies and contract research organizations are coming up with new medicines and therapy forms to treat a wide range of indications. Further, a strong demand for biologics and biosimilars to treat chronic diseases is, in turn, driving the growth of the biopharmaceutical industry. The biopharmaceutical industry is one of the most significant contributors to the economy. Factors such as increasing biologics approval, growing biosimilar pipeline, rising investment in research activities, and increasing focus on developing affordable biologics are facilitating the growth of the biopharmaceutical industry.

Apart from these, increasing approvals in gene and cell therapies are favoring the bioprocessing market growth. The approved gene therapies are Glybera (to treat lipoprotein lipase deficiency) and Strimvelis (to treat ADA-severe combined immunodeficiency). Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioprocessing market.

Europe Bioprocessing Market Overview

Biosimilars introduce competition and increase the affordability of biologics, which ultimately deliver savings and value-added services to support patient care and the healthcare industry. Healthcare professionals can treat more patients with high-quality biologics at reduced cost. Due to the massive potential for cost savings, the German Health Ministry introduced a new law to increase the adoption of biosimilars. Also, a growing number of partnerships among international players boost the market growth in the country. For instance, in November 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC and apceth Biopharma GmbH expanded their relationship with Bluebird Bio to enter into long-term development and manufacturing services agreements for clinical and commercial supply of multiple therapies, as well as expand commercial drug product manufacturing capacity in Europe for ZYNTEGLO, a one-time gene therapy for transfusion-dependent-thalassemia (TDT). Further, the biotechnology sector in Germany exhibits tremendous growth owing to the presence of numerous biotechnology companies, high-tech research labs, and massive funding for research and development. The growth of research and development in biopharmaceuticals and biologics is majorly driven by the adoption of various organic strategies by companies in the healthcare industry. For instance, in June 2021, Rentschler Biopharma expanded its production capacity with a 2,000-liter bioreactor to address the increasing demand for complex antibodies, a class of biopharmaceutical drugs with continued high potential. Likewise, in August 2023, Sartorius, one of the leading suppliers for the biopharmaceutical industry, collaborated with global technology and software leader Emerson to integrate Sartorius's Biostat STR Generation 3 family of bioreactors with Emerson's DeltaVTM distributed control system (DCS). Thus, the biopharmaceutical sector in the country is growing due to increasing R&D expenditure by biopharmaceutical companies. Thus, collaborative research efforts by biopharmaceutical and biotechnology companies in the country influence the market.

Europe Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Europe Bioprocessing Market Segmentation

The Europe bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

Based on product, the Europe bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Europe bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

By process, the Europe bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

Based on application, the Europe bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

In terms of end user, the Europe bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

By country, the Europe bioprocessing market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe bioprocessing market share in 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Europe bioprocessing market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioprocessing Market Landscape

4.1 Ecosystem Analysis
- 4.1.1 List of Vendors in the Value Chain

5. Europe Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
- 5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
- 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Europe Analysis

6.1 Europe Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Europe Bioprocessing Market Analysis - by Product

7.1 Overview
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
    - 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
    - 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
- 7.3.1 Overview
- 7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Europe Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview
8.2 Commercial Operations
- 8.2.1 Overview
- 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
- 8.3.1 Overview
- 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Bioprocessing Market Analysis - by Process

9.1 Overview
9.2 Downstream Bioprocess
- 9.2.1 Overview
- 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
- 9.3.1 Overview
- 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Bioprocessing Market Analysis - by Application

10.1 Overview
10.2 Monoclonal Antibodies
- 10.2.1 Overview
- 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
- 10.3.1 Overview
- 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
- 10.4.1 Overview
- 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
- 10.5.1 Overview
- 10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Bioprocessing Market Analysis - by End User

11.1 Overview
11.2 Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
- 11.3.1 Overview
- 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Bioprocessing Market - Country Analysis

12.1 Europe
- 12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
  - 12.1.1.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
  - 12.1.1.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product
    - 12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process
    - 12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application
    - 12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User
  - 12.1.1.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
  - 12.1.1.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
    - 12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
    - 12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
    - 12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
  - 12.1.1.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
  - 12.1.1.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product
    - 12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process
    - 12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application
    - 12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User
  - 12.1.1.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.7.1 Overview
  - 12.1.1.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product
    - 12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process
    - 12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application
    - 12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User
  - 12.1.1.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.9.1 Overview
  - 12.1.1.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product
    - 12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process
    - 12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application
    - 12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User
  - 12.1.1.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.11.1 Overview
  - 12.1.1.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
    - 12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
    - 12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
    - 12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 3M Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eppendorf SE
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Repligen Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Entegris Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Agilent Technologies Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Cytiva US LLC
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market

List Of Figures

Figure 1. Europe Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Europe: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market